CIK 0001551152 · Large accelerated filer
AbbVie Inc.
Sign in to watch- Ticker
- ABBV
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320375147
- Phone
- (847) 932-7900
- Business address
- 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, 60064
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,925,738
- in 1 filing
Net −$11,925,738. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-27 | SALEKI-GERHARDT AZITA EVP, CHIEF OPERATIONS OFFICER | Shares withheld for taxes | −16,309 | $232.08 | $3.8M | 197,794 |
| 2026-02-25 | Siatis Perry C EVP, GC AND SECRETARY | Option exercise 10b5-1 | +7,314 | $149.62 | $1.1M | 45,451 |
| 2026-02-25 | Siatis Perry C EVP, GC AND SECRETARY | Option exercise 10b5-1 | +7,775 | $175.28 | $1.4M | 53,226 |
| 2026-02-25 | Siatis Perry C EVP, GC AND SECRETARY | Option exercise 10b5-1 | +7,292 | $192.86 | $1.4M | 60,518 |
| 2026-02-25 | Siatis Perry C EVP, GC AND SECRETARY | Sale 10b5-1 | −22,381 | $230.00 | $5.1M | 38,137 |
| 2026-02-25 | Siatis Perry C EVP, GC AND SECRETARY | Option exercise · Option (Right to buy) 10b5-1 | −7,314 | $149.62 | $1.1M | 0 |
| 2026-02-25 | Siatis Perry C EVP, GC AND SECRETARY | Option exercise · Option (Right to buy) 10b5-1 | −7,775 | $175.28 | $1.4M | 7,774 |
| 2026-02-25 | Siatis Perry C EVP, GC AND SECRETARY | Option exercise · Option (Right to buy) 10b5-1 | −7,292 | $192.86 | $1.4M | 14,583 |
| 2026-02-18 | Crum Demetris D EVP, CHIEF HR OFFICER | Grant or award | +1,216 | 8,264 | ||
| 2026-02-18 | Crum Demetris D EVP, CHIEF HR OFFICER | Grant or award | +1,244 | 9,508 | ||
| 2026-02-18 | Crum Demetris D EVP, CHIEF HR OFFICER | Grant or award · Option (Right to buy) | +13,406 | 13,406 | ||
| 2026-02-18 | Purdue David Ryan SVP, Controller | Grant or award | +2,505 | 7,010 | ||
| 2026-02-18 | Purdue David Ryan SVP, Controller | Grant or award | +890 | 7,900 | ||
| 2026-02-18 | Purdue David Ryan SVP, Controller | Grant or award | +1,292 | 9,192 | ||
| 2026-02-18 | Purdue David Ryan SVP, Controller | Grant or award | +1,384 | 10,576 | ||
| 2026-02-18 | Purdue David Ryan SVP, Controller | Grant or award · Option (Right to buy) | +4,875 | 4,875 | ||
| 2026-02-18 | Thakkar Roopal EVP, R&D and CSO | Grant or award | +6,015 | 48,291 | ||
| 2026-02-18 | Thakkar Roopal EVP, R&D and CSO | Grant or award | +2,138 | 50,429 | ||
| 2026-02-18 | Thakkar Roopal EVP, R&D and CSO | Grant or award | +3,346 | 53,775 | ||
| 2026-02-18 | Thakkar Roopal EVP, R&D and CSO | Grant or award | +6,638 | 60,413 |
Page 3 of 12 · 231 trades